![Kenneth Hughes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Hughes
Geschäftsführer bei
MICROBIX BIOSYSTEMS INC.
Vermögen: 114 480 $ am 31.07.2026
Profil
Kenneth Hughes is the founder of PlantForm Corp., founded in 2008, and Roker Biotechnologies, Inc., founded in 2010, where the title held is President.
Dr. Hughes is currently Chief Operating Officer at Microbix Biosystems, Inc. since 2019.
Former jobs include President & Chief Executive Officer at Itp Biomedica Corp.
from 2014 to 2019, Research Scientist at Hemosol Corp., and Vice President-Scientific & Regulatory Affairs at Innovative Medicines Canada from 2011 to 2013.
Education includes a doctorate from the University of London conferred in 1990 and an undergraduate degree from The University of Sheffield.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MICROBIX BIOSYSTEMS INC. 0,39 % | 23.02.2026 | 540 000 ( 0,39 % ) | 114 480 $ | 31.07.2026 |
Aktive Positionen von Kenneth Hughes
| Unternehmen | Position | Beginn |
|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Geschäftsführer | 03.06.2019 |
Roker Biotechnologies, Inc. | Gründer | 01.01.2010 |
Ehemalige bekannte Positionen von Kenneth Hughes
| Unternehmen | Position | Ende |
|---|---|---|
Itp Biomedica Corp. | Vorstandsvorsitzender | 01.01.2019 |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines and vaccines | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 |
PlantForm Corp.
 PlantForm Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets plant-made pharmaceuticals | Gründer | - |
Hemosol Corp. /Old/
 Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Kenneth Hughes
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Microbix Biosystems, Inc.
 Microbix Biosystems, Inc. BiotechnologyHealth Technology Develops biological products and technologies | Health Technology |
Hemosol Corp. /Old/
Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines and vaccines | Commercial Services |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets plant-made pharmaceuticals | Health Technology |
Itp Biomedica Corp. | |
Roker Biotechnologies, Inc. |
